SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 82,499,000 | $120,618,000 | 3.75% |
| WOLVERINE ASSET MANAGEMENT LLC | 76,497,000 | $112,118,000 | 1.04% |
| Verition Fund Management LLC | 24,689,000 | $36,219,000 | 0.26% |
| Baker Brothers Advisors | 29,174,000 | $42,695,000 | 0.21% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 6,858,000 | $10,032,000 | 0.17% |
| LORD, ABBETT & CO. LLC | 48,435,000 | $71,054,000 | 0.16% |
| Calamos Advisors LLC | 21,131,000 | $30,817,000 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,218,000 | $4,726,000 | 0.10% |
| Point72 Asset Management, L.P. | 9,507,000 | $13,948,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 10,000,000 | $14,609,000 | 0.05% |